FDA Inspection 1038849 — Statline (division of MTF Biologics)

Statline (division of MTF Biologics) — FEI 3003447829

The FDA completed an inspection of Statline (division of MTF Biologics) on January 24, 2018 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Edison, NJ (United States)